Table 3.
Comparisons of previous treatment response and the best treatment response to mVNR (N=90).
| Response to previous treatment | CR, n (%) | PR, n (%) | SD, n (%) | DCR, n (%) | PD, n (%) | NE, n (%) |
|---|---|---|---|---|---|---|
| CR and PR, n=46 | 1(3.4) | 26 (62.1) | 10 (24.1) | 37 (80.4) | 8(3.4) | 1(6.9) |
| SD, n=14 | 0 | 6 (42.9) | 7 (50.0) | 13 (92.9) | 1(7.1) | 0 |
| PD, n=26 | 0 | 12 (46.2) | 5 (19.2) | 17 (65.4) | 8 (30.8) | 1 (3.8) |
| NE, n=4 | 1(25) | 2(50) | 1(25) | 4 (100) | 0 | 0 |
CR-complete response; PD-progressive disease; PR-partial response; SD-stable disease; DCR-disease control rate; NE-not evaluable.